Home/ Supplements/ Vitamin K/ Vein Support

Vein Support

product on market Capsule Doctor's Best Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Diosmin and orange extracts are supported by moderate evidence for improving venous tone and reducing swelling. Vitamin K2 plays a role in calcium metabolism and vascular health. Overall, the evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vein Support
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Veggie Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mcg (40% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)
DiosVein Diosmin EP
900 mg
Natural Orange extract
100 mg

Other Ingredients

Modified Cellulose Rice powder Glycerol Monostearate Magnesium Stearate Silicon Dioxide Ascorbyl Palmitate Rosemary extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Adult Use: Take 2 capsules daily. For optimal absorption, take with a fat-containing meal, or as recommended by a nutritionally-informed physician.

Warnings & Precautions

Warning: Contains vitamin K.

Consult your physician if using blood-thinning medications such as warfarin.

Formulation Notes

Doctor’s Best Vein Support contains DiosVein Diosmin, used for decades for vascular support in Europe. Derived from sweet orange and rich in bioflavonoids, DiosVein has been shown in clinical studies to support blood vessel health and support normal circulatory function.

Further studies have found that Diosmin in combination with the flavonoid hesperidin supports healthy venous function.

Vein Support also contains MenaQ7, a long-acting, natural form of Vitamin K2 purified from fermented chickpeas.

Adequate K2 is important for healthy blood vessel function and MenaQ7 is a long-acting form shown to support cardiovascular health.

Vein Support with DiosVein and MenaQ7 Vitamin K2 as MK-7

Vegan

Warning: Contains vitamin K.

Non-GMO Gluten free Soy free

Additional Information

Helps support blood vessel health Helps support normal circulatory function Helps support cardiovascular health

YDRB185-3

Helps support healthy circulation

Vegan

Store in a cool dry place.

Metadata

Product Details

UPC / SKU7 53950 00185 5
DSLD Entry Date2019-05-28
Product TypeOther Combinations
FormCapsule
DSLD ID203095
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.